Evidence map›Paper›PMID 31758392›Full record

ArticleHuman cell2020

miR-663b promotes colorectal cancer progression by activating Ras/Raf signaling through downregulation of TNK1.

Sen Hong, Zhenkun Yan, Helei Wang, Lei Ding, Yumei Song, Miaomiao Bi

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. MIR210HG Accelerates the Progression of Colorectal Cancer and Affects the Function of Colorectal Cancer Cells by Downregulating miR-1226-3p.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Sen HongDepartment of Colorectal and Anal Surgery, The First Hospital of Jilin University, Changchun, 130021, Jilin, People's Republic of China.
Zhenkun YanDepartment of Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, 130022, Jilin, People's Republic of China.
Helei WangDepartment of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, 130021, Jilin, People's Republic of China. wanghelei@foxmail.com.
Lei DingDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, 130022, Jilin, People's Republic of China. zr_doctord@163.com.
Yumei SongDepartment of Thoracic Oncology, Tumor Hospital of Jilin Province, Changchun, Jilin, People's Republic of China.
Miaomiao BiDepartment of Ophthalmology, The China-Japan Union Hospital of Jilin University, Jilin University, Changchun, 130022, Jilin, People's Republic of China.
Jilin University · CNUnion Hospital · CNFirst Hospital of Jilin University · CNJilin Province Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MiR-663b has been demonstrated to be abnormally expressed in several cancer types and was involved in the progression of cancer. Although overexpression of miR-663b in colorectal cancer was observed, the role of miR-663b in colorectal cancer cells has not been identified yet. In this study, we analyzed expression of miR-663b in colorectal tumors and explored the molecular mechanism of miR-663b in colorectal cancer cells. MiR-663b was significantly overexpressed in colorectal tumors and cell lines. Downregulation of miR-663b inhibited cell proliferation and sphere forming ability in colorectal cancer cells. In addition, miR-663b downregulation inactivated Ras/Raf signaling activity and subsequently decreased YAP1 and CD44 expression in colorectal cancer cells. Using TargetScan software, TNK1, a negative regulator of Ras/Raf signaling, was predicted to be a target gene of miR-663b. Western blotting and RT-qPCR showed that TNK1 expression was negatively regulated by miR-663b. In addition, the direct binding of miR-663b to TNK1 mRNA was proved by dual luciferase reporter assay. Furthermore, downregulation of miR-663b inhibited colorectal cancer cell proliferation and stemness, which was reversed after siRNA-mediated silencing of TNK1. In conclusion, the current study revealed a pivotal role of miR-663b in the progression of colorectal cancer.

Indexed as

Down-RegulationFetal ProteinsProtein-Tyrosine KinasesColorectal NeoplasmsDisease ProgressionHumansMicroRNAsSignal TransductionFetal ProteinsMicroRNAsMIRN663 microRNA, humanProtein-Tyrosine KinasesTNK1 protein, humanColorectal cancermicroR-663bTNK1

Identifiers

PMID31758392
OpenAlexW2991151930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.